Trial reportEuropean journal of heart failure2017
The effects of short-term omission of daily medication on the pathophysiology of heart failure.
Trial report in European journal of heart failure, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
31 citing papers in PubMed, 70 citations in OpenAlex.
- Positioning-robust broadband microwave transmission as a minimal-complexity approach to thoracic dielectric sensing: simulation and phantom analysis.Scientific reports · 2026Article
- Medication adherence in patients with acutely decompensated heart failure: A cross-sectional study in the emergency department (ADHF-ED).European journal of heart failure · 2025Article
- SGLT2 inhibitor with and without ALDosterone AntagonIst for heart failure with preserved ejection fraction: Design paper.ESC heart failure · 2025Article
- Intracardiac energy inefficiency during decompensated and compensated heart failure.ESC heart failure · 2025Article
- Pathophysiology of Congestion in Heart Failure: A Contemporary Review.Cardiac failure review · 2024Review
- Cardiovascular Consequences of Acute Kidney Injury: Treatment Options.Biomedicines · 2023Review
- Inferior vena cava diameter is associated with prognosis in patients with chronic heart failure independent of tricuspid regurgitation velocity.Clinical research in cardiology : official journal of the German Cardiac Society · 2023Article
- Extracorporeal veno-venous ultrafiltration in congestive heart failure: What's the state of the art? A mini-review.World journal of cardiology · 2023Review
- Congestion and Use of Diuretics in Heart Failure and Cardiomyopathies: a Practical Guide.Current cardiology reports · 2023Review
- Development and acceptance of a new adherence monitoring package to identify non-adherent patients with polypharmacy in primary care: a feasibility study.BMJ open quality · 2023Article
- Conduction System Pacing: Have We Finally Found the Holy Grail of Physiological Pacing?Heart international · 2023Review
- Aiming at harmony. Comparing and contrasting International HFrEF Guidelines.European heart journal supplements : journal of the European Society of Cardiology · 2022Article
- Clinical implications of left atrial changes after optimization of medical therapy in patients with heart failure.European journal of heart failure · 2022Article
- Endomyocardial fibrosis of the right ventricle in a patient with schistosomiasis: a case report.European heart journal. Case reports · 2022Article
- Article
- Use of diuretics and outcomes in patients with type 2 diabetes: findings from the EMPA-REG OUTCOME trial.European journal of heart failure · 2021Article
- Ultrasound imaging of congestion in heart failure: examinations beyond the heart.European journal of heart failure · 2021Review
- Range of adiposity and cardiorenal syndrome.World journal of diabetes · 2020Review
- Higher doses of loop diuretics limit uptitration of angiotensin-converting enzyme inhibitors in patients with heart failure and reduced ejection fraction.Clinical research in cardiology : official journal of the German Cardiac Society · 2020Observational
- Caring for people with heart failure and many other medical problems through and beyond the COVID-19 pandemic: the advantages of universal access to home telemonitoring.European journal of heart failure · 2020Article
Corrections and comments
- Commented on by
Authors and funding
6 authors at 4 institutions in 4 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimsPharmacological therapies for heart failure (HF) aim to improve congestion, symptoms, and prognosis. Failing to take medication is a potential cause of worsening HF. Characterizing the effects of short-term medication omission could inform the development of better technologies and strategies to detect and interpret the reasons for worsening HF. We examined the effect of planned HF medication omission for 48 h on weight, echocardiograms, transthoracic bio-impedance, and plasma concentrations of NT-proBNP. METHODS AND
resultsOutpatients with stable HF and an LVEF <45% were assigned to take or omit their HF medication for 48 h in a randomized, crossover trial. Twenty patients (16 men, LVEF 32 ± 9%, median NT-proBNP 962 ng/L) were included. Compared with regular medication, omission led to an increase in NT-proBNP by 99% (from 962 to 1883 ng/L, P < 0.001), systolic blood pressure by 16% (from 131 to 152 mmHg, P < 0.001), and left atrial volume by 21% (from 69 to 80 mL, P = 0.001), and reductions in transthoracic bio-impedance by 10% (from 33 to 30 Σ, P = 0.001) and serum creatinine by 8% (from 135 to 118 µmol/L, P = 0.012). No significant changes in body weight, heart rate, or LVEF were observed.
conclusionsThe characteristic pattern of response to short-term medication omission is of increasing congestion but, in contrast to the pattern reported for disease progression, with a rise in blood pressure and improved renal function. In stable HF, weight is not a sensitive marker of short-term diuretic omission.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.